Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Xenon Pharmaceuticals Inc. (XENE)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.00.00.00.10.58.83.78.1
            Revenue growth  -100.0%-100.0%-100.0%-98.4%-75.8%101.1%-27.4%24.0%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.10.58.83.78.1
            Gross margin     100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]55.649.143.338.330.926.128.623.7
Research and development          
Other operating expenses  -15.9-15.2-14.2-0.81.85.40.50.1
EBITDA   [+]-39.1-33.5-28.7-37.0-31.7-22.4-25.1-15.5
            EBITDA margin     -28021.2%-5915.3%-255.3%-670.4%-190.7%
Depreciation and amortization  0.60.40.50.40.40.40.30.2
EBIT   [+]-39.7-33.8-29.2-37.3-32.1-22.8-25.3-15.7
            EBIT margin     -28292.4%-5985.3%-259.6%-677.6%-193.3%
Interest income  6.55.44.53.10.80.40.20.1
Other income (expense), net  -14.5-13.0-11.5-3.50.12.30.10.0
Pre-tax income  -47.7-41.4-36.3-37.7-31.2-20.1-25.1-15.7
Income taxes  -0.20.31.1-0.60.0-0.40.5-0.2
            Tax rate  0.5%  1.6%0.1%2.0% 1.3%
Net income  -47.5-41.7-37.4-37.2-31.2-19.7-25.6-15.4
            Net margin     -28143.9%-5813.1%-224.4%-684.1%-190.1%
   
Basic EPS   [+]($0.72)($0.63)($0.62)($0.57)($0.55)($0.36)($0.59)($0.37)
Diluted EPS   [+]($0.72)($0.63)($0.62)($0.57)($0.55)($0.36)($0.59)($0.37)
   
Shares outstanding (basic)   [+]65.965.760.565.556.254.943.642.3
Shares outstanding (diluted)   [+]65.965.760.565.556.254.943.642.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy